340 related articles for article (PubMed ID: 28143674)
1. SA4Ag, a 4-antigen Staphylococcus aureus vaccine, rapidly induces high levels of bacteria-killing antibodies.
Begier E; Seiden DJ; Patton M; Zito E; Severs J; Cooper D; Eiden J; Gruber WC; Jansen KU; Anderson AS; Gurtman A
Vaccine; 2017 Feb; 35(8):1132-1139. PubMed ID: 28143674
[TBL] [Abstract][Full Text] [Related]
2. Safety, tolerability, and immunogenicity of a single dose 4-antigen or 3-antigen Staphylococcus aureus vaccine in healthy older adults: Results of a randomised trial.
Creech CB; Frenck RW; Sheldon EA; Seiden DJ; Kankam MK; Zito ET; Girgenti D; Severs JM; Immermann FW; McNeil LK; Cooper D; Jansen KU; Gruber W; Eiden J; Anderson AS; Baber J
Vaccine; 2017 Jan; 35(2):385-394. PubMed ID: 27866765
[TBL] [Abstract][Full Text] [Related]
3. Safety, tolerability, and immunogenicity of a 4-antigen Staphylococcus aureus vaccine (SA4Ag): Results from a first-in-human randomised, placebo-controlled phase 1/2 study.
Frenck RW; Creech CB; Sheldon EA; Seiden DJ; Kankam MK; Baber J; Zito E; Hubler R; Eiden J; Severs JM; Sebastian S; Nanra J; Jansen KU; Gruber WC; Anderson AS; Girgenti D
Vaccine; 2017 Jan; 35(2):375-384. PubMed ID: 27916408
[TBL] [Abstract][Full Text] [Related]
4. A randomized phase I study of the safety and immunogenicity of three ascending dose levels of a 3-antigen Staphylococcus aureus vaccine (SA3Ag) in healthy adults.
Nissen M; Marshall H; Richmond P; Shakib S; Jiang Q; Cooper D; Rill D; Baber J; Eiden J; Gruber W; Jansen KU; Emini EA; Anderson AS; Zito ET; Girgenti D
Vaccine; 2015 Apr; 33(15):1846-54. PubMed ID: 25707693
[TBL] [Abstract][Full Text] [Related]
5. Persistence of Immune Responses Through 36 Months in Healthy Adults After Vaccination With a Novel
Creech CB; Frenck RW; Fiquet A; Feldman R; Kankam MK; Pathirana S; Baber J; Radley D; Cooper D; Eiden J; Gruber WC; Jansen KU; Anderson AS; Gurtman A
Open Forum Infect Dis; 2020 Jan; 7(1):ofz532. PubMed ID: 31993453
[TBL] [Abstract][Full Text] [Related]
6. Safety, tolerability, and immunogenicity of a novel 4-antigen
Inoue M; Yonemura T; Baber J; Shoji Y; Aizawa M; Cooper D; Eiden J; Gruber WC; Jansen KU; Anderson AS; Gurtman A
Hum Vaccin Immunother; 2018; 14(11):2682-2691. PubMed ID: 30084709
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity of a Staphylococcus aureus-cholera toxin A
Misra N; Wines TF; Knopp CL; Hermann R; Bond L; Mitchell B; McGuire MA; Tinker JK
Vaccine; 2018 Jun; 36(24):3513-3521. PubMed ID: 29739718
[TBL] [Abstract][Full Text] [Related]
8. Efficacy profile of a bivalent Staphylococcus aureus glycoconjugated vaccine in adults on hemodialysis: Phase III randomized study.
Fattom A; Matalon A; Buerkert J; Taylor K; Damaso S; Boutriau D
Hum Vaccin Immunother; 2015; 11(3):632-41. PubMed ID: 25483694
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of approaches to monitor Staphylococcus aureus virulence factor expression during human disease.
Rozemeijer W; Fink P; Rojas E; Jones CH; Pavliakova D; Giardina P; Murphy E; Liberator P; Jiang Q; Girgenti D; Peters RP; Savelkoul PH; Jansen KU; Anderson AS; Kluytmans J
PLoS One; 2015; 10(2):e0116945. PubMed ID: 25719409
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to Staphylococcus aureus serotype 8 capsular polysaccharide react with and protect against serotype 5 and 8 isolates.
Park S; Gerber S; Lee JC
Infect Immun; 2014 Dec; 82(12):5049-55. PubMed ID: 25245803
[TBL] [Abstract][Full Text] [Related]
11. Safety and immunogenicity of a booster dose of a 3-antigen Staphylococcus aureus vaccine (SA3Ag) in healthy adults: A randomized phase 1 study.
Marshall H; Nissen M; Richmond P; Shakib S; Jiang Q; Cooper D; Rill D; Baber J; Eiden J; Gruber WC; Jansen KU; Anderson AS; Zito ET; Girgenti D
J Infect; 2016 Nov; 73(5):437-454. PubMed ID: 27519620
[TBL] [Abstract][Full Text] [Related]
12. Preclinical Efficacy of Clumping Factor A in Prevention of Staphylococcus aureus Infection.
Li X; Wang X; Thompson CD; Park S; Park WB; Lee JC
mBio; 2016 Feb; 7(1):e02232-15. PubMed ID: 26838725
[TBL] [Abstract][Full Text] [Related]
13. Protein antigens increase the protective efficacy of a capsule-based vaccine against Staphylococcus aureus in a rat model of osteomyelitis.
Lattar SM; Noto Llana M; Denoël P; Germain S; Buzzola FR; Lee JC; Sordelli DO
Infect Immun; 2014 Jan; 82(1):83-91. PubMed ID: 24126523
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of serotypes 5 and 8 capsular polysaccharides in protection against Staphylococcus aureus in murine models of infection.
Cheng BL; Nielsen TB; Pantapalangkoor P; Zhao F; Lee JC; Montgomery CP; Luna B; Spellberg B; Daum RS
Hum Vaccin Immunother; 2017 Jul; 13(7):1609-1614. PubMed ID: 28422567
[TBL] [Abstract][Full Text] [Related]
15. c-di-GMP as a vaccine adjuvant enhances protection against systemic methicillin-resistant Staphylococcus aureus (MRSA) infection.
Hu DL; Narita K; Hyodo M; Hayakawa Y; Nakane A; Karaolis DK
Vaccine; 2009 Jul; 27(35):4867-73. PubMed ID: 19406185
[TBL] [Abstract][Full Text] [Related]
16. Vaccination as infection control: a pilot study to determine the impact of Staphylococcus aureus vaccination on nasal carriage.
Creech CB; Johnson BG; Alsentzer AR; Hohenboken M; Edwards KM; Talbot TR
Vaccine; 2009 Dec; 28(1):256-60. PubMed ID: 19799842
[TBL] [Abstract][Full Text] [Related]
17. Safety and immunogenicity of an investigational 4-component Staphylococcus aureus vaccine with or without AS03B adjuvant: Results of a randomized phase I trial.
Levy J; Licini L; Haelterman E; Moris P; Lestrate P; Damaso S; Van Belle P; Boutriau D
Hum Vaccin Immunother; 2015; 11(3):620-31. PubMed ID: 25715157
[TBL] [Abstract][Full Text] [Related]
18. The development of a staphylococcus aureus four antigen vaccine for use prior to elective orthopedic surgery.
Gurtman A; Begier E; Mohamed N; Baber J; Sabharwal C; Haupt RM; Edwards H; Cooper D; Jansen KU; Anderson AS
Hum Vaccin Immunother; 2019; 15(2):358-370. PubMed ID: 30215582
[TBL] [Abstract][Full Text] [Related]
19. Vaccination against Staphylococcus aureus experimental endocarditis using recombinant Lactococcus lactis expressing ClfA or FnbpA.
Veloso TR; Mancini S; Giddey M; Vouillamoz J; Que YA; Moreillon P; Entenza JM
Vaccine; 2015 Jul; 33(30):3512-7. PubMed ID: 26048778
[TBL] [Abstract][Full Text] [Related]
20. DNA immunization of dairy cows with the clumping factor A of Staphylococcus aureus.
Nour El-Din AN; Shkreta L; Talbot BG; Diarra MS; Lacasse P
Vaccine; 2006 Mar; 24(12):1997-2006. PubMed ID: 16426711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
